- Biodesix to Provide COVID-19 Testing for Colorado State University Campus
- The United States Court of Appeals for the Federal Circuit Affirms That 10x Genomics Willfully Infringed Bio-Rad U.S. Patent and Upholds Lower Court’s Award of Damages
- Bio-Rad Reports Second-Quarter 2020 Financial Results
- Bio-Rad to Report Second-Quarter 2020 Financial Results, Thursday, July 30, 2020
Bio Rad Laboratories Inc (BIO:NYQ) closed at 517.91, -4.10% below its 52-week high of 540.06, set on Jul 30, 2020.
309.38Mar 23 2020540.06Jul 30 2020
Markit short selling activity
|Market cap||15.21bn USD|
|EPS (TTM)||64.46 |
Data delayed at least 15 minutes, as of Sep 21 2020 21:10 BST.